Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 juin 2019 00h56 HE | Source: ORPHAZYME A/S

Orphazyme to prepare for filing of arimoclomol in Europe for Niemann-Pick disease Type C (NPC)

Orphazyme A/SCompany announcement No....
31 mai 2019 10h49 HE | Source: ORPHAZYME A/S

Major shareholder announcement

Orphazyme A/SCompany announcement No. 14/2019 Company Registration No. 32266355 ...
23 avr. 2019 06h39 HE | Source: ORPHAZYME A/S

Orphazyme’s Phase II/III trial in sporadic Inclusion Body Myositis fully enrolled

Orphazyme A/SCompany announcement No. 13/2019 ...
17 avr. 2019 09h29 HE | Source: ORPHAZYME A/S

Major shareholder announcement

Orphazyme A/SCompany announcement No. 12/2019Company Registration No. 32266355 ...
29 mars 2019 03h09 HE | Source: ORPHAZYME A/S

Share capital and voting rights in Orphazyme A/S

Orphazyme A/SCompany announcement No....
27 mars 2019 14h06 HE | Source: ORPHAZYME A/S

Resolution passed at the Annual General Meeting

Orphazyme A/SCompany announcement No....
11 mars 2019 04h12 HE | Source: ORPHAZYME A/S

Orphazyme to present at Cowen & Co Annual Health Care Conference

Orphazyme A/SInvestor news No....
08 mars 2019 04h10 HE | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....
07 mars 2019 14h34 HE | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....
05 mars 2019 09h51 HE | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....

Page précédente